Your support network is there to help you through thick and thin. And so are we. From friendly scientific advice to recombinant antibodies that work every time, we’re here for you. https://bit.ly/3bFUoaO
About us
At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
- Website
-
https://www.abcam.com/
External link for abcam
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- antibodies, custom services, proteins, gene-edited cell lines, knockout cell lines, rabbit antibodies, immunoassays, biological reagents, monoclonal antibodies, research, drug discovery , diagnostics, RabMAb, and Life Sciences
Locations
Employees at abcam
Updates
-
Don’t miss Graham Heieis' film - part five of @abcam's Love Letters to Science! OUT NOW! https://bit.ly/3QOcQBV #ProgressHappensTogether #LoveLettersToScience #Abcam #PeopleBehindTheScience
-
What does an effective mentor-mentee relationship look like to you? Join us at PEGS Boston this year to find out from our VP of Protein Development, Deborah Moore-La. Deborah will share insights into what this looks like for her in an exclusive panel discussion on mentorship. Visit the Marquee Room to delve into what it means to be a mentor, finding the perfect match, and ensuring a supportive environment for junior scientists. See the full PEGS schedule here: https://bit.ly/4dGbYJ2
-
Great to be a part of YCharOS Inc.’s first annual symposium last week - an important meet-up of the YCharOS Industry Advisory Committee to discuss strategies to characterize antibodies against the entire human proteome. An ambitious yet vital project to improve reproducibility in scientific research and ultimately speed up progress towards better biological understanding and improved treatments and health outcomes for all 🙌 Find out more about the role of the Industry Advisory Committee, here: https://lnkd.in/eVrs6ZR6
Last week, we convened our inaugural face-to-face YCharOS meeting, bringing together representatives from Canadian funding agencies, antibody manufacturers, pharmaceutical companies, and academia at McGill University. The objective of the meeting was to strategize how to scale this academic initiative from testing antibodies for 100 proteins to the human proteome. Through panel discussions, reverse brainstorming (thanks Hannah C. – but is it typical to fill up the entire whiteboard in few minutes with potential future problems 😉), and various presentations, we identified several potential strategies that will require a few more weeks to digest. We'll provide a summary of the meeting along with our forward strategy. A big thank you to our antibody manufacturer partners—abcam, ABclonal Technology, Aviva Systems Biology,Bio-Techne, ABCD Antibodies, Cell Signaling Technology (CST), DSHB, GeneTex, Inc., Institute for Protein Innovation, Proteintech Group, Synaptic Systems GmbH, Thermo Fisher Scientific, YCharOS Inc. —for making the YCharOS project possible and for attending the meeting. Who can guess the type of IgG represented in that picture?
-
At Abcam, we rigorously validate our antibodies and proteins using advanced QC methods, ensuring the highest quality and reproducibility for your assays. Check out our poster #B003 at PEGS Boston this year to learn more about our quality processes. Learn more here: https://bit.ly/3Qqxh7H
-
We’re at PEGS Boston 2024! Find Abcam at the Danaher booth #500 & meet our experts: Deborah Moore-Lau, VP of Protein Development, and Will Howat, VP of Quality and Validation. Click the link for more info and to schedule a meeting with our team: https://bit.ly/3Qqxh7H
-
That first moment of inspiration feels great. But it’s even better when you show that it’s right. We’ve got over 32,000 high-performance antibodies to help you reach that moment. Together, we move forward faster. https://bit.ly/3bFUoaO
-
📢 New publication alert! Our collaborators at @Weizmann Institute of Science use integrative spatial analysis techniques to reveal new insights into the cellular organization and role of hypoxia within glioblastomas, the most aggressive and most common brain cancer. Read the paper in @Cell Press to find out more: https://bit.ly/3yc3Yzz To find out more about the technical and scientific approach behind this paper, including choosing the right reagents and integrating them into the workflow – read our accompanying application note, here: https://lnkd.in/ePaqP2EH
-
“We take pride in knowing that we make a meaningful difference to our customers.” Ben Gordon, Logistics Manager. From the lab to logistics, all roles at Abcam play a part in supporting our customers. That’s because when you work at Abcam, no matter your team, we share a passion for bringing scientists one step closer to their next breakthrough. Click the link to learn more about our purpose and impact, and how you can get involved. https://bit.ly/4a9rOcs
-
Congratulations to Emily on reaching an incredible milestone of 10 years at Abcam! 🎉✨ Your dedication, talent, and passion have made a lasting impact. We are grateful to have you as part of our team. 🙌 We spoke to Emily to find out what she loved most about working for Abcam, and here’s what she said: “I’ve had a number of roles in Abcam since joining in 2014, all in Abcam’s Digital team. I currently lead the Digital Transformation Office, a team that acts as an information hub for all our digital products, projects and programmes. This role has given me the opportunity to be involved in some of Abcam’s most strategically important initiatives and have the privilege to work with so many talented people across all other functions in Abcam. I love the variety in my role and that every day brings a new opportunity to connect with people, solve challenges and collaborate on important topics.” Interested in joining our Digital team? Find out about the Digital Technology & Data jobs we have available here: https://lnkd.in/ePNbSEpH
Today I'm celebrating 10 years at abcam and what an incredible 10 years it's been. I've had the privilege to work alongside so many talented and passionate people (far too many to name here, but I appreciate you all!), I've had the opportunity to work on some of the most challenging and rewarding projects of my career, and I've learnt and grown as an individual and a leader. I'm continually grateful for these opportunities! #progresshappenstogether #bestteamwins